We administered dichloroacetate, which prevents or reverses hyperlactatemia in animals and lowers plasma lactate levels in human beings, to 13 patients with lacticacidosis of various causes. All had hypotension, and their acidemia had resisted treatment with sodium bicarbonate. The metabolic effects of dichloroacetate were evaluated in 11 patients. In seven dichloroacetate significantly reduced the level of arterial blood lactate (P less than 0.005) from the base-line value and raised the levels of arterial blood bicarbonate (P less than 0.02) and arterial pH (P less than 0.005). In six of these seven, the acidemia resolved completely with therapy. In 10 of the 13 patients systolic blood pressure increased by 10 to 40 mm Hg, and 4 patients had a 21 per cent increase in cardiac output (P less than 0.02). Despite improvement in their lactic acidemia, all patients but one died of their underlying disease. No serious drug-related toxicity occurred. We conclude that dichloroacetate is a safe and effective adjunct in the treatment of patients with lacticacidosis, although the ultimate prognosis may depend on the underlying disease.
This article has been cited by other articles:
ANDERSON, K.M., JAJEH, J., GUINAN, P., RUBENSTEIN, M.
(2009). In Vitro Effects of Dichloroacetate and CO2 on Hypoxic HeLa Cells. Anticancer Res
29: 4579-4588
[Abstract][Full Text]
Thatte, H. S., Rousou, L., Hussaini, B. E., Lu, X.-G., Treanor, P. R., Khuri, S. F.
(2009). Development and Evaluation of a Novel Solution, Somah, for the Procurement and Preservation of Beating and Nonbeating Donor Hearts for Transplantation. Circulation
120: 1704-1713
[Abstract][Full Text]
Mercken, E. M., Calvert, L. D., Singh, S. J., Hageman, G. J., Schols, A. M., Steiner, M. C.
(2009). Dichloroacetate Modulates the Oxidative Stress and Inflammatory Response to Exercise in COPD. Chest
136: 744-751
[Abstract][Full Text]
Schultz, I. R., Shangraw, R. E.
(2006). Effect of Short-Term Drinking Water Exposure to Dichloroacetate on its Pharmacokinetics and Oral Bioavailability in Human Volunteers: A Stable Isotope Study. Toxicol Sci
92: 42-50
[Abstract][Full Text]
Kaufmann, P., Engelstad, K., Wei, Y., Jhung, S., Sano, M. C., Shungu, D. C., Millar, W. S., Hong, X., Gooch, C. L., Mao, X., Pascual, J. M., Hirano, M., Stacpoole, P. W., DiMauro, S., De Vivo, D. C.
(2006). Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial. Neurology
66: 324-330
[Abstract][Full Text]
Cryer, D. R., Nicholas, S. P., Henry, D. H., Mills, D. J., Stadel, B. V.
(2005). Comparative Outcomes Study of Metformin Intervention Versus Conventional Approach The COSMIC Approach Study. Diabetes Care
28: 539-543
[Abstract][Full Text]
Misbin, R. I.
(2004). The Phantom of LacticAcidosis due to Metformin in Patients With Diabetes. Diabetes Care
27: 1791-1793
[Full Text]
Stacpoole, P. W., Nagaraja, N. V., Hutson, A. D.
(2003). Efficacy of Dichloroacetate as a Lactate-Lowering Drug. J Clin Pharmacol
43: 683-691
[Abstract][Full Text]
Lantum, H. B. M., Baggs, R. B., Krenitsky, D. M., Board, P. G., Anders, M. W.
(2002). Immunohistochemical Localization and Activity of Glutathione Transferase Zeta (GSTZ1-1) in Rat Tissues. Drug Metab. Dispos.
30: 616-625
[Abstract][Full Text]
CIUFO, R., DIMARCO, A., STOFAN, D., NETHERY, D., SUPINSKI, G.
(2001). Dichloroacetate Reduces Diaphragmatic Lactate Formation But Impairs Respiratory Performance. Am. J. Respir. Crit. Care Med.
164: 1669-1674
[Abstract][Full Text]
Forsythe, S. M., Schmidt, G. A.
(2000). Sodium Bicarbonate for the Treatment of LacticAcidosis*. Chest
117: 260-267
[Abstract][Full Text]
Howlett, R. A., Heigenhauser, G. J. F., Hultman, E., Hollidge-Horvat, M. G., Spriet, L. L.
(1999). Effects of dichloroacetate infusion on human skeletal muscle metabolism at the onset of exercise. Am. J. Physiol. Endocrinol. Metab.
277: E18-E25
[Abstract][Full Text]
Dishart, M. K., Schlichtig, R., Tonnessen, T. I., Rozenfeld, R. A., Simplaceanu, E., Williams, D., Gayowski, T. J. P.
(1998). Mitochondrial redox state as a potential detector of liver dysoxia in vivo. J. Appl. Physiol.
84: 791-797
[Abstract][Full Text]
Misbin, R. I., Green, L., Stadel, B. V., Gueriguian, J. L., Gubbi, A., Fleming, G. A.
(1998). LacticAcidosis in Patients with Diabetes Treated with Metformin. NEJM
338: 265-266
[Full Text]
Gueriguian, J., Green, L., Misbin, R. I., Stadel, B., Fleming, G. A., Deutsch, J.C., Santhosh-Kumar, C.R., Kolhouse, J.F., DeFronzo, R. A., Goodman, A. M.
(1996). Efficacy of Metformin in Non-Insulin-Dependent Diabetes Mellitus. NEJM
334: 269-270
[Full Text]
Gan, S. C., Barr, J., Arieff, A. I., Pearl, R. G.
(1992). Biguanide-Associated LacticAcidosis: Case Report and Review of the Literature. Arch Intern Med
152: 2333-2336
[Abstract]
Ozand, P. T., Gascon, G. G.
(1991). Topical Review Article: Organic Acidurias: A Review Part 2. J Child Neurol
6: 288-303
[Abstract]
Wakeford, J. H., Hardin, T. C.
(1991). Sepsis. Journal of Pharmacy Practice
4: 269-280
Rauss, A., Knaus, W. A., Patois, E., Le Gall, J.-R., Loirat, P.
(1990). Prognosis for Recovery from Multiple Organ system failure: The Accuracy of Objective Estimates of Chances for Survival. Med Decis Making
10: 155-162
[Abstract]
Cooper, D. J., Walley, K. R., Wiggs, B. R., Russell, J. A.
(1990). Bicarbonate Does Not Improve Hemodynamics in Critically III Patients Who Have LacticAcidosis: A Prospective, Controlled Clinical Study. ANN INTERN MED
112: 492-498
[Abstract]
STACPOOLE, P. W., LORENZ, A. C., THOMAS, R. G., HARMAN, E. M.
(1988). Dichloroacetate in the Treatment of LacticAcidosis. ANN INTERN MED
108: 58-63
[Abstract]
Kreisberg, R. A.
(1987). LacticAcidosis: An Update. J Intensive Care Med
2: 76-84
[Abstract]
STACPOOLE, P. W.
(1986). LacticAcidosis: The Case Against Bicarbonate Therapy. ANN INTERN MED
105: 276-279
[Abstract]
Graf, H, Leach, W, Arieff, A.
(1985). Evidence for a detrimental effect of bicarbonate therapy in hypoxic lacticacidosis. Science
227: 754-756
[Abstract]